Relamorelin Reduces Vomiting Frequency and Severity and Accelerates Gastric Emptying in Adults With Diabetic Gastroparesis

Posted on April 4, 2016 by Anthony Lembo, Michael Camilleri, Richard McCallum, Ramon Sastre, Cristian Breton, Sharon Spence, Jeffery White, Michelle Currie, Keith Gottesdiener, Elizabeth Stoner, RM-131-004 Trial Group

Gastroparesis is an important complication of diabetes. We investigated the effects of relamorelin (a pentapeptide-selective agonist of the ghrelin receptor that speeds gastric emptying in patients with diabetes) in patients with diabetic gastroparesis.

This entry was posted in News. Bookmark the permalink.